|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net income (loss) | ||||
| Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Write-off of deferred financing costs from early payoff of debt | ||||
| Share-based compensation | ||||
| Provision for doubtful accounts | ||||
| Amortization of premiums on marketable securities | ||||
| Change in fair value of warrant liabilities | ||||
| Deferred income tax (benefit) expense | ||||
| Other | ||||
| Change in operating assets and liabilities: | ||||
| Trade and other receivables | ||||
| Prepaid expenses and other current assets | ||||
| Other non-current assets | ||||
| Accounts payable | ||||
| Accrued expenses and other liabilities | ||||
| Deferred revenue | ||||
| Other non-current liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Investing activities | ||||
| Acquisition of businesses, net of cash acquired | ||||
| Acquisition of property and equipment, including capitalization of internal use software | ||||
| Acquisition of intangible assets | ||||
| Purchases of marketable securities | ||||
| Sale and maturities of marketable securities | ||||
| Premiums paid for company-owned life insurance policies | ||||
| Decrease in restricted cash | ||||
| Net cash used in investing activities | ||||
| Financing activities | ||||
| Term loan | ||||
| Initial public offering, net of offering costs | ||||
| Issuance of convertible redeemable preferred stock, net of offering costs | ||||
| Issuance of warrants | ||||
| Proceeds from stock based compensation plans | ||||
| Payments to Series E-1 convertible redeemable preferred stockholders | ||||
| Proceeds from warrant exercises | ||||
| Payments for employee tax withholdings related to restricted stock units and awards | ||||
| Payments for debt issuance costs | ||||
| Net cash provided by financing activities | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of year | ||||
| Cash and cash equivalents at end of year | ||||
| Supplemental cash flow information: | ||||
| Cash paid (refunded) during the period for: | ||||
| Interest | ||||
| Income taxes | ||||
| Supplemental information for non-cash investing activities: | ||||
| Accrued capital expenditures | ||||
| Property and equipment acquired through leasehold incentives | ||||
| Convertible redeemable preferred stock issued as part of purchase price for ID Analytics | ||||
| Preferred stock embedded derivative issued as part of purchase price for ID Analytics | ||||
Loading...